Dimorphic fungal osteoarticular infections

This study demonstrates that dimorphic osteoarticular infections have distinctive clinical presentations, occur predominantly in apparently immunocompetent patients, develop often during disseminated disease, and may require surgical intervention.
Source: European Journal of Clinical Microbiology and Infectious Diseases - Category: Microbiology Source Type: research

Related Links:

Abstract Primary extranodal lymphoma is defined as a lymphoma at a solitary extranodal site, with or without involvement of the lymph nodes. The clinical and radiological features of extranodal lymphoma have been documented in recent studies. In this pictorial essay, we reviewed imaging findings of extranodal lymphoma in the head and neck region.Resumo Linfoma extranodal prim ário é definido como um sítio extranodal solitário de linfoma, com ou sem envolvimento dos gânglios linfáticos. As características clínicas e radiológicas do linfoma extranodal foram docume...
Source: Radiologia Brasileira - Category: Radiology Source Type: research
ABSTRACT Cicatricial ectropion may be a consequence of certain systemic diseases as well as the result of drug use. Our goal here was to research the different causes of this condition as reported in the literature, including more recently suspected etiologies. A detailed PubMed literature search indicated many different etiologies were associated with cicatricial ectropion development, from severe cases of systemic diseases, such as ichthyosis and lupus erythematosus, to reversible scenarios secondary to anti-glaucomatous drug use. More recently reported connections include periorbital necrotizing fasciitis, frontal osteo...
Source: Arquivos Brasileiros de Oftalmologia - Category: Opthalmology Source Type: research
ABSTRACT Cicatricial ectropion may be a consequence of certain systemic diseases as well as the result of drug use. Our goal here was to research the different causes of this condition as reported in the literature, including more recently suspected etiologies. A detailed PubMed literature search indicated many different etiologies were associated with cicatricial ectropion development, from severe cases of systemic diseases, such as ichthyosis and lupus erythematosus, to reversible scenarios secondary to anti-glaucomatous drug use. More recently reported connections include periorbital necrotizing fasciitis, frontal osteo...
Source: Arquivos Brasileiros de Oftalmologia - Category: Opthalmology Source Type: research
ABSTRACT Cicatricial ectropion may be a consequence of certain systemic diseases as well as the result of drug use. Our goal here was to research the different causes of this condition as reported in the literature, including more recently suspected etiologies. A detailed PubMed literature search indicated many different etiologies were associated with cicatricial ectropion development, from severe cases of systemic diseases, such as ichthyosis and lupus erythematosus, to reversible scenarios secondary to anti-glaucomatous drug use. More recently reported connections include periorbital necrotizing fasciitis, frontal osteo...
Source: Arquivos Brasileiros de Oftalmologia - Category: Opthalmology Source Type: research
Sammy Margo, a physiotherapist in North London, and Dr Rod Hughes, a consultant rheumatologist, give the lowdown on gadgets and remedies for the pain. We then rated them.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Bioengineers and dentists from the UCLA School of Dentistry have developed a new hydrogel that is more porous and effective in promoting tissue repair and regeneration compared to hydrogels that are currently available. Once injected in a mouse model, the new hydrogel is shown to induce migration of naturally occurring stem cells to better promote bone healing. Current experimental applications using hydrogels and stem cells introduced into the body or expensive biological agents can come with negative side effects.The  findings, published online in the journal Nature Communications, suggest that in the near future th...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
Upadacitinib is for adults with moderately to severely active rheumatoid arthritis who fail to respond adequately or are intolerant to methotrexate.FDA Approvals
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Alert Source Type: news
Conditions:   Chronic Pain;   Low Back Pain;   Fibromyalgia;   Upper Extremity Dysfunction;   Complex Regional Pain Syndromes;   Phantom Limb Pain;   Rheumatoid Arthritis;   Carpal Tunnel Syndrome;   Repetitive Strain Injury Intervention:   Device: Karuna Labs Virtual Reality Software Sponsor:   Karuna Labs Inc. Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
America is going gray. According to U.S. Census data, in 2030 even the youngest Baby Boomers will have reached 65, and older Americans will make up 21 percent of the population. That’s up from 15 percent today. By 2060, nearly a quarter of Americans will be at least 65 and a half million will reach age 100. These changing demographics give urgency to the concept of “aging in place.” Nobody wants to lose their independence, but that’s the reality for many who are forced from their homes by cardiovascular disease, stroke, cancer, diabetes or other chron...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news
(Reuters)—The U.S. Food and Drug Administration (FDA) on Friday approved AbbVie Inc.’s new treatment for rheumatoid arthritis (RA), a win for the drugmaker seeking to widen its portfolio as its blockbuster flagship therapy Humira (adalimumab)‎‎ faces competition. The drug, Rinvoq (upadacitinib), is a JAK inhibitor. It is set to compete with Pfizer Inc.’s Xeljanz (tofacitinib)... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: DMARDs & Immunosuppressives Drug Updates AbbVie Inc FDA FDA approval Rheumatoid Arthritis (RA) U.S. Food and Drug Administration (FDA) upadacitinib Source Type: research
More News: Arthritis | Coccidioidomycosis (Valley Fever) | Dermatology | Infectious Diseases | Microbiology | Osteomyelitis | Rheumatology | Study